Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

Original COVID-19 Shots No Longer “Authorized for Use” in the United States

The FDA announced Tuesday that the monovalent Pfizer and Moderna COVID-19 shots are no longer “authorized for use” in the United States.

The “monovalent” shots are the original COVID-19 shots administered to the public for the two-dose primary series.

From the FDA:

Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals 6 months of age and older, including for an additional dose or doses for certain populations. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.

How many Americans were coerced into taking this poison or fired from their jobs for refusing to take the shots?

Now, they’re suddenly unauthorized for use in the United States.

Perhaps Joe Biden signing a resolution to end the fake COVID-19 emergency had something to do with the amended emergency use authorizations (EUAs).

JUST IN: Biden Signs Law Declaring COVID-19 ‘Emergency’ Over

The FDA's announcement has many people asking 'why now?'

Elon Musk asked "why," and the FDA responded.

If the COVID-19 "emergency" was declared over, then why is any shot "authorized for emergency use?"

The FDA's move also caught the attention of James O'Keefe.

"Can someone from the FDA please tell me what’s going on here?" O'Keefe asked.

Other Twitter users commented on the FDA's decision to pull the monovalent COVID-19 shots:


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Leave a comment
Thanks for sharing!